Finance

Lists
Why is 31R down 30.00%?
Dive Deeper
31R:FRA
Revive Therapeutics Ltd
€0.010
-30.00%
(-0.0045) 1D
Oct 8, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
12.51M
Avg. vol.
2.94K
Volume
0.00
52-wk high
€0.06
52-wk low
€0.00
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
12.51M
Avg. vol.
2.94K
Volume
0.00
52-wk high
€0.06
52-wk low
€0.00
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Canada
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336.32K
200.14K
283.25K
242.05K
Operating expense
336.39K
220.13K
283.30K
463.87K
Total operating expenses
336.39K
220.13K
283.30K
463.87K
Operating income
-336.39K
-220.13K
-283.30K
-463.87K
Other non operating income
73.85K
-
-
-
EBT including unusual items
-9.60M
-281.75K
-238.72K
-506.50K
EBT excluding unusual items
-143.94K
-281.75K
-234.70K
-506.50K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.60M
-281.75K
-238.72K
-506.50K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277.00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277.00
-
-
Depreciation and amortization charges
62.00
46.00
48.00
47.00
EBITDA
-336.32K
-220.08K
-283.25K
-463.82K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps